Linlin Sun

Dr. Linlin Sun


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
FXFanfan Xing
Fanfan Xing
HCHei Yeung Kelvin Chiu
Hei Yeung Kelvin Chiu
Chaowen DengChaowen Deng
Chaowen Deng
HYhaiyan ye
haiyan ye
LSLinlin Sun
Linlin Sun
KYKwok-Yung Yuen
Kwok-Yung Yuen
The rebound characteristics of respiratory infections after lifting pandemic control measures were uncertain. From January to November 2023, patients presenting at a teaching hospital were tested for common respiratory viruses and Mycoplasma pneumoniae using a combination of antigen, nucleic acid amplification, and targeted next-generation sequencing (tNGS) tests. The number and rate of positive tests per month, clinical and microbiological characteristics were analyzed. A rapid rebound of SARS-CoV-2 was followed by a slower rebound of M. pneumoniae, with an interval of 5 months between their peaks. The hospitalization rate was higher, with infections caused by respiratory viruses compared to M. pneumoniae. Though the pediatric hospitalization rate of respiratory viruses (66.1%) was higher than that of M. pneumoniae (34.0%), the 4094 cases of M. pneumoniae within 6 months posed a huge burden on healthcare services. Multivariate analysis revealed that M. pneumoniae-infected adults had more fatigue, comorbidities, and higher serum C-reactive protein, whereas children had a higher incidence of other respiratory pathogens detected by tNGS or pathogen-specific PCR, fever, and were more likely to be female. A total of 85% of M. pneumoniae-positive specimens had mutations detected at the 23rRNA gene, with 99.7% showing A2063G mutation. Days to defervescence were longer in those not treated by effective antibiotics and those requiring a change in antibiotic treatment. A delayed but significant rebound of M. pneumoniae was observed after the complete relaxation of pandemic control measures. No unusual, unexplained, or unresponsive cases of respiratory infections which warrant further investigation were identified.

27 April 2024 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Open access
DYDongjie Yu
Dongjie Yu
YLYuansen Luo
Yuansen Luo
LSLinlin Sun
Linlin Sun
We report a case of septic arthritis in a 43-year-old female patient. Despite initial treatment with ceftriaxone for Nontyphoidal Salmonella based on blood and joint fluid culture results, the shoulder joint pain worsened. Suspected systemic lupus erythematosus associated synovitis did not respond to immunosuppressive therapy including methylprednisolone, hydroxychloroquine and methotrexate. Subsequent radiograph revealed a shoulder joint abscess, leading to arthroscopic joint debridement. Ceftriaxone was administered post-operatively until analgesic efficacy was attained. This case highlights the significance of accurate diagnosis and appropriate treatment for nontyphoidal Salmonella septic arthritis.

21 June 2025 in IDCases
Verified
Journal Article
Open access
DYDongjie Yu
Dongjie Yu
LSLinlin Sun
Linlin Sun
Nontyphoidal Salmonella septic arthritis is an uncommon complication of NTS bacteremia in adults. A 75-year-old patient was admitted for right hip pain, presenting with manifestations of septic shock. Following a series of examinations, the patient was diagnosed with nontyphoidal Salmonella septic hip arthritis. Treatment included antibiotics, debridement, and the implantation of a spacer. The patient recovered and was able to ambulate slowly with a cane. The patient ultimately opted for continued oral antibiotic therapy to avoid infection recurrence, rather than undergoing a two-stage total hip replacement, after achieving satisfactory activities of daily life.